DDX17 induces epithelial-mesenchymal transition and metastasis through the miR-149-3p/CYBRD1 pathway in colorectal cancer

[1]  Mingli Yang,et al.  Molecular Network of Colorectal Cancer and Current Therapeutic Options , 2022, Frontiers in Oncology.

[2]  Cun-Yu Wang,et al.  PHLDB2 Mediates Cetuximab Resistance via Interacting With EGFR in Latent Metastasis of Colorectal Cancer , 2021, Cellular and molecular gastroenterology and hepatology.

[3]  H. Deng,et al.  DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasis , 2021, Hepatology.

[4]  Jian Tang,et al.  Long non-coding RNA MEG3 mediates the miR-149-3p/FOXP3 axis by reducing p53 ubiquitination to exert a suppressive effect on regulatory T cell differentiation and immune escape in esophageal cancer , 2021, Journal of translational medicine.

[5]  Jingjing Zhao,et al.  Identification of gene signatures and potential therapeutic targets for acquired chemotherapy resistance in gastric cancer patients. , 2021, Journal of gastrointestinal oncology.

[6]  H. Kuasne,et al.  Circulating let-7e-5p, miR-106a-5p, miR-28-3p, and miR-542-5p as a Promising microRNA Signature for the Detection of Colorectal Cancer , 2021, Cancers.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  Kai Li,et al.  ACLY: A biomarker of recurrence in breast cancer. , 2020, Pathology, research and practice.

[9]  P. Zhao,et al.  The long non-coding RNA HOXA11-AS promotes epithelial mesenchymal transition by sponging miR-149-3p in Colorectal Cancer , 2020, Journal of Cancer.

[10]  Jing-Yuan Fang,et al.  Comprehensive review of targeted therapy for colorectal cancer , 2020, Signal Transduction and Targeted Therapy.

[11]  Hongcheng Luo,et al.  Upregulation of DEAD box helicase 5 and 17 are correlated with the progression and poor prognosis in gliomas. , 2020, Pathology, research and practice.

[12]  Jun Zhao,et al.  miR‐190b promotes tumor growth and metastasis via suppressing NLRC3 in bladder carcinoma , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Q. Cui,et al.  miR-190b promotes colorectal cancer progression through targeting forkhead box protein P2 , 2019, Experimental and therapeutic medicine.

[14]  Jie Yao,et al.  Upregulation Of miR-149-3p Suppresses Spinal Chordoma Malignancy By Targeting Smad3 , 2019, OncoTargets and therapy.

[15]  M. Fassan,et al.  PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target , 2019, Cancers.

[16]  Y. Liang,et al.  Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway , 2019, Oncogene.

[17]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[18]  Qilu Huang,et al.  LINC00472 Acts as a Tumor Suppressor in NSCLC through KLLN-Mediated p53-Signaling Pathway via MicroRNA-149-3p and MicroRNA-4270 , 2019, Molecular therapy. Nucleic acids.

[19]  T. Vanden Berghe,et al.  Targeting Ferroptosis to Iron Out Cancer. , 2019, Cancer cell.

[20]  Z. Ji,et al.  Long noncoding RNA SNHG20 promotes prostate cancer progression via upregulating DDX17 , 2019, Archives of medical science : AMS.

[21]  C. Curtis,et al.  Quantitative evidence for early metastatic seeding in colorectal cancer , 2019, Nature Genetics.

[22]  Wei-Chung Cheng,et al.  Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features. , 2019, Cancer research.

[23]  Elizabeth J. Tran,et al.  The DDX5/Dbp2 subfamily of DEAD‐box RNA helicases , 2018, Wiley interdisciplinary reviews. RNA.

[24]  Pingping Wu,et al.  Overexpression of miR‐301a‐3p promotes colorectal cancer cell proliferation and metastasis by targeting deleted in liver cancer‐1 and runt‐related transcription factor 3 , 2018, Journal of cellular biochemistry.

[25]  G. Meister,et al.  Regulation of microRNA biogenesis and its crosstalk with other cellular pathways , 2018, Nature Reviews Molecular Cell Biology.

[26]  N. Tan,et al.  High expression of ALDOA and DDX5 are associated with poor prognosis in human colorectal cancer , 2018, Cancer management and research.

[27]  Michael B. Stadler,et al.  Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells , 2018, Cell Death & Differentiation.

[28]  Yuan Li,et al.  DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin. , 2017, Cancer letters.

[29]  Jinyong Peng,et al.  Potent effects of dioscin against pancreatic cancer via miR‐149‐3P‐mediated inhibition of the Akt1 signalling pathway , 2017, British journal of pharmacology.

[30]  C. Punt,et al.  From tumour heterogeneity to advances in precision treatment of colorectal cancer , 2017, Nature Reviews Clinical Oncology.

[31]  T. Tsukamoto,et al.  18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling , 2016, Oncotarget.

[32]  J. Reményi,et al.  The miRNA biogenesis factors, p72/DDX17 and KHSRP regulate the protein level of Ago2 in human cells. , 2016, Biochimica et biophysica acta.

[33]  F. Torti,et al.  Iron and cancer: recent insights , 2016, Annals of the New York Academy of Sciences.

[34]  K. Gopal,et al.  DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer. , 2016, Cellular signalling.

[35]  Yong Peng,et al.  The role of MicroRNAs in human cancer , 2016, Signal Transduction and Targeted Therapy.

[36]  M. Fakih.  Metastatic colorectal cancer: current state and future directions. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  M. Ghosh,et al.  The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis , 2015, Oncogene.

[38]  J. Mariadason,et al.  Implications of Epithelial–Mesenchymal Plasticity for Heterogeneity in Colorectal Cancer , 2015, Front. Oncol..

[39]  Brian S. Cole,et al.  Stem-Loop Recognition by DDX17 Facilitates miRNA Processing and Antiviral Defense , 2014, Cell.

[40]  X. Zhao,et al.  SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer , 2014, Cell Death and Differentiation.

[41]  L. Tranchevent,et al.  RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation. , 2014, Cell reports.

[42]  F. Camargo,et al.  Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer , 2014, Cell.

[43]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[44]  F. Fuller-Pace,et al.  The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. , 2008, Cancer research.

[45]  H. Uhlmann-Schiffler,et al.  Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation , 2007, Nucleic acids research.

[46]  F. Fuller-Pace.  DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation , 2006, Nucleic acids research.

[47]  G. Berx,et al.  Modulation of iron transport proteins in human colorectal carcinogenesis , 2006, Gut.

[48]  J. Coxhead,et al.  Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.